Browse All

Current Filters

CLEAR FILTER x

TITLE

The Use of Intraoperative Neuromonitoring to Predict Post-Operative Delirium in Patients Undergoing Cardiac Surgery: A Retrospective Study

Author:Al Ta'ani, Omar   Subramaniam, Kathirvel   Al Qudah, Abdullah   Gorijala, Vamsi Krishna   Sadhasivam, Senthilkumar   Vogt, Keith   Nadkarni, Neelesh   Kiselevskaya, Victoria   Thirumala, Parthasarathy   

Session Name:N1: Neuroscience in the Clinic: Predicting, Evaluating, and Modifying Risk of Delirium  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:N1.002  

Author Institution:University of Pittsburgh Medical Center, Pittsburgh, PA  

Weight Loss and Disease Progression in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis

Author:Lee, Ikjae   Mitsumoto, Hiroshi   Factor-Litvak, Pam   Nieves, Jeri   

Session Name:P2: Neuromuscular Disease: ALS, SMA, and Other Motor Neuron Disorders 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P2.009  

Author Institution:Columbia University Irving Medical Center, New York, NY  Mailman School of Public Health, New York, NY  

Clinical characterisation of encephalitis of unknown cause and ‘mimics’ of encephalitis.

Author:Liem, Bernard   Liem, Michelle   Anderson, Neil   

Session Name:P4: Autoimmune Neurology: Autoimmune Encephalitis / Paraneoplastic / Stiff-Person Syndrome / Immunotherapy (IrAe)  

Topic:Autoimmune Neurology  

Program Number:P4.004  

Author Institution:Department of Neurology, Auckland City Hospital, Auckland, New Zealand  

Pediatric CLIPPERS? Think Again!

Author:Zhou, Daniel   Darwish, Mohamed   Ford, James   Patel, Sachit   Koh, Sookyong   Rathore, Geetanjali   Zabad, Rana   

Session Name:P5: Autoimmune Neurology: Autoimmune Encephalitis / Paraneoplastic Neurologic Disorders 1  

Topic:Autoimmune Neurology  

Program Number:P5.032  

Author Institution:University of Nebraska Medical Center, Omaha, NE  Children's Mercy Kansas City, Kansas City, MO  Children's Hospital & Medical Center, Omaha, NE  

Ublituximab, a Novel, Glycoengineered Anti-CD20 Monoclonal Antibody (mAb), Demonstrates Enhanced Antibody-Dependent Cellular Cytotoxicity (ADCC) Relative to Other Anti-CD20 mAbs

Author:Huang, Deren   Alvarez, Enrique   Miskin, Hari   Lee, Lily   Foley, John   

Session Name:P7: MS Therapeutics 1  

Topic:MS and Inflammatory Disease  

Program Number:P7.011  

Author Institution:Mount Carmel Neurology, Powell, OH  University of Colorado, Aurora, CO  TG Therapeutics, New York, NY  Rocky Mountain MS Clinic, Salt Lake City, UT